PIV-Vol2 | PIV-Vol2-001 | to be reviewed | Testable |
8
|
5
| | The Communicate Infusion Order [PCD-03] transaction references the following chapters from the HL7 Version 2.6 standard: Chapter 4 Order Entry | 17 | Section 3.3.3 Referenced Standard | 2/28/16 8:46:04 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-002 | to be reviewed | Testable |
8
|
4
| | The Communicate Infusion Order [PCD-03] transaction references the IEEE 11073-10101a Nomenclature standard | 17 | Section 3.3.3 Referenced Standard | 2/28/16 8:46:05 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-003 | to be reviewed | Testable |
8
|
5
| | The static definition for the PCD-03 Communicae Infusion Order (RGV^O15^RGV_O15) is in Table 3.3.4.2-1: RGV^O15^RGV_O15 Pharmacy/Treatment Give Message | 18 | Table Table 3.3.4.2-1: RGV^O15^RGV_O15 Pharmacy/Treatment Give Message | 2/28/16 8:46:06 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-004 | to be reviewed | Testable |
8
|
5
| | Refer to the HL7 standard for the RGV message in HL7 2.6 Chapter 4 for the general message semantics. | 20 | Section 3.3.4.4 Message Semantics | 2/28/16 8:46:33 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-005 | to be reviewed | Testable |
8
|
5
| | For the PCD-03 message MSH-15 Accept Acknowledgement Type shall contain AL. | 20 | Section 3.3.4.4.1 MSH â Message Header Segment | 2/28/16 8:46:07 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-006 | to be reviewed | Testable |
8
|
5
| | The Accept Acknowledgement message shall be transmitted by the IOC actor to the IOP actor on the same network connection as the initiating RGV^O15 or RRG^O16 message received by the IOC actor. | 20 | Section 3.3.4.4.1 MSH â Message Header Segment | 2/28/16 8:46:08 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-007 | to be reviewed | Testable |
8
|
5
| | In the PCD-03 message the MSH-16 Application Acknowledgement field shall always be populated. | 20 | Section 3.3.4.4.1 MSH â Message Header Segment | 2/28/16 8:46:09 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-008 | to be reviewed | Testable |
8
|
5
| | When the IOP actor requests an application acknowledgement the IOC actor shall initiate a new network connection for the transmission of the message. | 20 | Section 3.3.4.4.1 MSH â Message Header Segment | 2/28/16 8:46:10 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-009 | to be reviewed | Testable |
8
|
4
| | After the IOP completes processing the IOP shall not transmit an Application Acknowledgement to the IOC. | 22 | Section 3.3.4.4.1 MSH â Message Header Segment | 2/28/16 8:46:31 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-010 | to be reviewed | Testable |
8
|
5
| | For the PCD-03 message the value of the MSH-16 Application Acknowledgement Type field shall be one of the values in the table. | 22 | Table Table 3.3.4.4.1-1: Possible Values for MSH-16 in PCD-03 Message | 2/28/16 8:46:13 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-011 | to be reviewed | Testable |
8
|
4
| | This profile recommends AL (always) for the value of the MSH-16 Application Acknowledgement Type field in the PCD-03 message to receive complete messaging processing confirmation. If this support is not feasible, this profile recommends that the IOP value the application acknowledgement field with ER (error/reject), so that the IOC will only send an application error when it is unable to process the requested order. | 22 | Section 3.3.4.4.1 MSH âÃÂàMessage Header Segment | 2/28/16 8:46:14 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-012 | to be reviewed | Testable |
8
|
4
| | This profile recommends that the IOC value the application acknowledgement field with NE on a RRG^O16, so that the IOP will only send an accept acknowledgement and not an application acknowledgement. | 22 | Section 3.3.4.4.1 MSH â Message Header Segment | 2/28/16 8:46:15 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-013 | to be reviewed | Testable |
8
|
4
| | Segment population of the PCD-03 RXG message shall conform to this table. | 23 | Table Table 3.3.4.4.5-1: HL7® Attribute Table â RXG â Pharmacy/Treatment Give | 2/28/16 8:46:27 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-014 | to be reviewed | Testable |
8
|
4
| | For the PCD-03 message the RXG-1 Give Sub-ID Counter field must contain a unique number for the placer order number. This field value along with the placer order number provides a unique reference to the specific administaion of the order. | 23 | Section 3.3.4.4.5 RXG - Pharmacy/Treatment Give Segment | 2/28/16 8:46:16 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-015 | to be reviewed | Testable |
8
|
4
| | In the PD-03 message the RXG-4 Give Code field the CWE-1 Identifier component shall be populated with an NDC or a value known to both the IOP and the IOC actors. | 24 | Section 3.3.4.4.5 RXG - Pharmacy/Treatment Give Segment | 2/28/16 8:46:17 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-016 | to be reviewed | Testable |
8
|
4
| | In the PCD-03 message the RXG-4 Give Code field the CWE-2 Text component shall be populated with an NDC or a value known both to the IOP and the IOC actor. | 24 | Section 3.3.4.4.5 RXG - Pharmacy/Treatment Give Segment | 2/28/16 8:46:18 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-017 | to be reviewed | Testable |
8
|
5
| | In the PCD-03 message the RXG-4 Give Code field the information provided in either the Identifier or Text components shall be used to match the ordered medication to the on-board drug library. | 24 | Section 3.3.4.4.5 RXG - Pharmacy/Treatment Give Segment | 2/28/16 8:46:20 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-018 | to be reviewed | Testable |
8
|
5
| | In the PCD-03 message the RXG-5 Give Amount - Minimum field if populated shall indicate the volume of fluid to be administered (VTBI - Volume To Be Infused). | 24 | Section 3.3.4.4.5 RXG - Pharmacy/Treatment Give Segment | 2/28/16 8:46:21 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-019 | to be reviewed | Testable |
8
|
5
| | In the PCD-03 message the RXG-5 Give Amount - Minimum field shall be present for LVP (Large Volume Pump) type pumps (as defined by the RXR-3 Administration Device field) when the TQ1 segment is not present. | 24 | Section 3.3.4.4.5 RXG - Pharmacy/Treatment Give Segment | 2/28/16 8:46:22 AM by mpattillo |
|
PIV-Vol2 | PIV-Vol2-020 | to be reviewed | Testable |
8
|
5
| | In the PCD-03 message the RXG-5 Give Amount - Minimum is optional for PCA (Patient Controlled Anesthesia) type pumps (as defined by the RXR-3 Administration Device field). | 24 | Section 3.3.4.4.5 RXG - Pharmacy/Treatment Give Segment | 2/28/16 8:46:23 AM by mpattillo |
|